{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:02:59Z","timestamp":1792652579551,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4880,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/modpathol.2009.89","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T09:59:32Z","timestamp":1245405572000},"page":"1133-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":192,"title":["Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers"],"prefix":"10.1016","volume":"22","author":[{"given":"Patricia A","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Rouzbahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen S","family":"Pizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Pintilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Begley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.89_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1200\/JCO.2004.07.179","article-title":"Biology of epithelial ovarian cancer: implications for screening women at high genetic risk","volume":"22","author":"Hogg","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Supp 1","key":"10.1038\/modpathol.2009.89_bib2","first-page":"214A","article-title":"Mucosal epithelial proliferation and p53 overexpression are frequent in women with BRCA mutations (Abstract)","volume":"17","author":"Shaw","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.89_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1038\/modpathol.2009.89_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2009.89_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.89_bib6","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1038\/modpathol.2009.89_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7827-1-70","article-title":"Ovarian surface epithelium: family history and early events in ovarian cancer","volume":"1","author":"Wong","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1038\/modpathol.2009.89_bib8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2009.89_bib9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"91","author":"Stratton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2009.89_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","article-title":"Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes","volume":"89","author":"Barakat","year":"2000","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.89_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004347-199904000-00009","article-title":"Histopathologic features of ovaries at increased risk for carcinoma. A case\u2013control analysis","volume":"18","author":"Sherman","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.89_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib15","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.89_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004347-199504000-00003","article-title":"Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?","volume":"14","author":"Yanai-Inbar","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.89_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2009.89_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.89_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004347-200004000-00007","article-title":"Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment","volume":"19","author":"Yanai-Inbar","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.89_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.89_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J of Surg Pathol"},{"key":"10.1038\/modpathol.2009.89_bib22","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.89_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1999.5568","article-title":"Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature","volume":"75","author":"Hornreich","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","article-title":"The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","volume":"104","author":"Beiner","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.89_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2009.89_bib29","first-page":"3193","article-title":"Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers","volume":"58","author":"Rhei","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.89_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jnci\/88.3-4.173","article-title":"The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry","volume":"88","author":"Sjogren","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2009.89_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jcp.52.5.372","article-title":"Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations","volume":"52","author":"Zweemer","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2009.89_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2004.08.035","article-title":"No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers","volume":"95","author":"Aghmesheh","year":"2004","journal-title":"Gynecol Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol200989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200989","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:59:40Z","timestamp":1760230780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0893395222024644"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.89","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.89","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}